Home/ Supplements/ Lysine/ L-Lysine

L-Lysine

product on market Capsule SuperiorLabs Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
120
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Plant Cellulose organic Rice concentrate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Formulation Notes

Amino acid

100% natural Pure and potent Promotes feelings of well-being Maintain muscle mass Support immune function Support calcium absorption

L-Lysine capsules manufactured by Superior Labs contain 500 mg pure L-Lysine with absolutely no magnesium stearate, dioxides, preservatives or other potentially harmful artificial ingredients of any kind.

L-Lysine capsules manufactured by Superior Labs contain 500 mg pure L-Lysine with absolutely no magnesium stearate, dioxides, preservatives or other potentially harmful artificial ingredients of any kind.

This product is formulated, developed and manufactured in a FDA registered and GMP certified facility, 3rd party inspected by a leading compliance authority for superior quality assurance.

Does Not Contain: Magnesium stearate, dioxides, preservatives, or artificial ingredients of any kind.

Additional Information

Metal Safe Heavy Metal Tested Made in USA Certified GMP Facility

Metadata

Product Details

UPC / SKU8 50569 00607 0
DSLD Entry Date2021-10-22
Product TypeAmino acid/Protein
FormCapsule
DSLD ID255999
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.